Showing results (321-330 of 513) with videos related to
Sort By:
Pageof 52
AIDS Research and Therapy|July 23, 2021
Persons living with HIV in sero-discordant partnerships experience improved HIV care engagement compared with persons living with HIV in sero-concordant partnerships: a cross-sectional analysis of four African countriesDomonique M Reed, Allahna L Esber, Trevor A Crowell, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 19, 2010
Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer studyH-H Sherry Chow, Linda L Garland, Chiu-Hsieh Hsu, et al.Mutation Research|March 28, 2007
Evaluation of chemopreventive agents for genotoxic activityRupa S Doppalapudi, Edward S Riccio, Linda L Rausch, et al.AIDS (London, England)|September 5, 2021
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020Trevor A Crowell, Ibrahim I Daud, Jonah Maswai, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2004
Single-dose pharmacokinetic study of lycopene delivered in a well-defined food-based lycopene delivery system (tomato paste-oil mixture) in healthy adult male subjectsDavid M Gustin, Keith A Rodvold, Jeffery A Sosman, et al.Psychonomic Bulletin & Review|March 3, 2007
Fruitful visual search: inhibition of return in a virtual foraging taskLaura E Thomas, Michael S Ambinder, Brendon Hsieh, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2021
Transient Reductions in Human Immunodeficiency Virus (HIV) Clinic Attendance and Food Security During the Coronavirus Disease 2019 (COVID-19) Pandemic for People Living With HIV in 4 African CountriesNicole Dear, Emma Duff, Allahna Esber, et al.Journal of Cellular Biochemistry. Supplement|January 1, 1994
Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development ProgramV E Steele, R C Moon, R A Lubet, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2022
Disengagement From HIV Care and Failure of Second-Line Therapy in Nigeria: A Retrospective Cohort Study, 2005-2017Kate El Bouzidi, Fati Murtala-Ibrahim, Vivian Kwaghe, et al.Urology|April 11, 2001
Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancerG J Kelloff, R Lieberman, V E Steele, et al.Pageof 52